Sarah M. McLeod
- Molecular Biology
- Molecular Medicine top 0.5%
- Genetics top 5%
- Pharmacology top 5%
- Endocrinology top 2%
- Co-authors
- Alita A. MillerReid C. JohnsonMatthew K. WaldorSamir H. MoussaAdam B. ShapiroMeredith HackelRichard L. GourseSarah E. Aiyar
- Topics
- Antibiotic Resistance in Bacteria (32 papers)Antibiotics Pharmacokinetics and Efficacy (20 papers)Vibrio bacteria research studies (10 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Sarah M. McLeod
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 579
- Molecular Medicine 577
- Genetics 401
- Pharmacology 307
- Endocrinology 250
Countries citing papers authored by Sarah M. McLeod
This map shows the geographic impact of Sarah M. McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. McLeod more than expected).
Fields of papers citing papers by Sarah M. McLeod
This network shows the impact of papers produced by Sarah M. McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. McLeod. The network helps show where Sarah M. McLeod may publish in the future.
Co-authorship network of co-authors of Sarah M. McLeod
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. McLeod. A scholar is included among the top collaborators of Sarah M. McLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. McLeod. Sarah M. McLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 7 | |
| 3 | 5 | |
| 4 | 9 | |
| 5 | 6 | |
| 6 | 23 | |
| 7 | 23 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 11 | |
| 12 | 3 | |
| 13 | 25 | |
| 14 | 6 | |
| 15 | 9 | |
| 16 | 59 | |
| 17 | 12 | |
| 18 | 121 | |
| 19 | 61 | |
| 20 | 24 |
About Sarah M. McLeod
Sarah M. McLeod is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (32 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Vibrio bacteria research studies (10 papers). The work is most often cited by research in Molecular Medicine (577 citations), Applied Microbiology and Biotechnology (145 citations) and Endocrinology (250 citations). Sarah M. McLeod has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Alita A. Miller, Reid C. Johnson, Matthew K. Waldor, Samir H. Moussa, Adam B. Shapiro, Meredith Hackel, Richard L. Gourse, Sarah E. Aiyar, James A. Karlowsky and Shin‐ichiro Narita. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.